New Evidence Supports the Value of Elutia’s Antibiotic-Eluting Platform for Implantable Devices
New Evidence Supports the Value of Elutia's Antibiotic-Eluting Platform for Implantable Devices GlobeNewswire July 01, 2025 — The EluPro BioEnvelope findings demonstrate the bioactive properties and superior healing response compared to synthetic materials for cardiac implantable electronic devices (CIEDs) — GAITHERSBURG, Md., July 01, 2025 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the […]